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ABSTRACT 
Human Immunodeficiency Virus (HIV) is a lentivirus that causes Acquired 
Immunodeficiency Syndrome (AIDS) resulting in the progressive failure of the immune 
system. Due to its rapid replication rate and high mutation frequency, the virus is able to 
evade the immune system and thwart an efficacious response. Current HIV infection 
prophylaxes and therapeutics are not optimal and there is an urgent need to develop an 
efficacious HIV vaccine. Recently, high-throughput sequencing of the Immunoglobulin 
(Ig) repertoire from HIV-infected humans and immunized Rhesus macaques has led to 
important insights into vaccines against HIV-1. Further elucidation of the antibody 
response in these crucial animal studies will require substantially greater power to 
analyze the Ig repertoires than is currently possible. Reliable information on macaque Ig 
genes is insufficient due to the incompleteness of the whole genome sequence (WGS) 
and the inherent difficulty of obtaining complete Ig sequences due to its complex and 
repetitive nature. To address this issue, we have generated a high quality, annotated WGS 
with precisely annotated Ig loci from ten macaques. We used low error, synthetic long 
reads generated by Illumina TruSeq technology, Illumina 150bp, paired-end reads (110X 
coverage) and Irys genome mapping technology to assemble the genome de novo. We 
 
 
ix 
 
employed a bait-and-sequence strategy using human Ig probes to capture macaque Ig 
genes for the accurate assembly and annotation of Ig genes and alleles. Together, these 
data will generate a complete Rhesus macaque genome with detailed information on 
allelic diversity at the Ig loci. This study is essential for making the macaque a viable 
model for adaptive immunity. In addition, it will provide information on the similarities 
and differences between macaque and human Ig genes that will aid in the design and 
interpretation of vaccine studies. 
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CHAPTER ONE: INTRODUCTION 
Rhesus macaques as animal models in biomedical research  
Historically, the Rhesus macaque (Macaca mulatta) has played a major role in the 
development of the rabies, smallpox, and polio vaccines1 and in establishing etiology of 
yellow fever and prion diseases. Given their similarity to human physiology, 
neuroanatomy, reproduction, development and their susceptibility to metabolic and 
human infectious diseases2, the rhesus macaque is one of the most important animal 
models used in biomedicine. Compared to mice that share a common ancestor with 
humans over 70 million years ago, macaques and humans share a common ancestor as 
recently as 25 million years ago3. This close phylogenetic relationship between macaques 
and humans enable greater validity in the data obtained from these primate models and 
help answer questions that cannot be addressed by other animal models2. For example, 
macaques and humans share similar etiology and arterial pathology, making them 
excellent models to study coronary heart diseases2. Macaques have had an enormous 
impact in the field of infectious diseases—they have served as the primary animal model 
in understanding over 70 human infectious diseases of diverse etiologies. Additionally, 
experiments on macaques contribute critical information such as safety and potential 
efficacy of vaccine candidates in pre-clinical trials. Currently, macaques as animal 
models are uniquely valuable and most promising in vaccinology studies for, human 
immunodeficiency virus (HIV), influenza virus, hepatitis E virus, Helicobacter pylori and 
Plasmodium species1.   
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Rhesus macaques and their use in HIV vaccine research 
HIV is the causative agent of acquired immunodeficiency syndrome (AIDS). While HIV 
does not infect macaques, a chimeric form of the Simian Immunodeficiency virus (SIV), 
referred to as SHIV, is used to infect macaques1. Macaques infected with SHIV, follow a 
similar course of infection as HIV and are currently the best animal models available for 
HIV vaccine research4. They have contributed immensely to our understanding of the 
disease4. SIV and HIV are closely related lentiviruses and share similar molecular 
makeup and pathogenesis in their susceptible host4. Over the course of infection, patients 
experience a decline in CD4+ cells (primarily T cells and macrophages) leading to 
immune deficiency5. While antiretroviral therapy has prolonged the lives of infected 
individuals6, no cure has yet been achieved. There is currently no FDA approved vaccine 
for HIV. Recently, several encouraging findings have been published in the HIV vaccine 
field using macaques as animal models. Early administration of potent HIV-1 specific 
human monoclonal antibodies in SHIV infected infant macaques completely halted 
infection7, and passive immunization of these potent antibodies reduced plasma viremia 
to undetectable levels in adult SHIV-infected macaques8. In a preventative setting, Adeno 
Associated virus expressed eCD4-Ig could protect macaques against multiple SHIV 
challenges9.  Additionally, we continue to gain insights into HIV vaccine design from 
these animal models10–12. 
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HIV vaccine design and broadly neutralizing antibodies:  
Antibodies are the predominant mechanism of protection in vaccines. An efficacious 
immune response is often reliant on specific antibody generation and diversification that 
is shaped by affinity maturation. The major challenges with development of an HIV 
vaccine are the high mutation rate of HIV, the ability of HIV to integrate into the host 
genome and establish latency and glycoprotein masking13.  Although the virus does elicit 
a host immune response, HIV evolves under selective immune pressure14 and is able to 
evade the immune system and thwart an effective immune response. A small percentage 
of infected individuals are able to produce broadly neutralizing antibodies (bnAbs) which 
are capable of neutralizing a broad spectrum of the virus. Though the bnAbs are not 
useful for the individual, one goal in HIV vaccine development is to elicit these 
antibodies that recognize conserved regions on viruses early upon administration of an 
immunogen15.  
 
Vaccines, Antibodies and V-D-J recombination:  
A robust vaccine response is dependent on the generation of a diverse repertoire of 
Antibodies (Ab) that are secreted by B-lymphocyte antigen receptors (BCR). BCRs are 
assembled by somatic recombination of a large number of Ig gene segments which is 
continuously shaped by exposure to antigens and host factors. Abs are generated by an 
ordered series of gene rearrangement events that occur in developing B cells throughout 
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the lifetime of an organism. A mature Ab consists of two heavy and two light chains 
linked by disulfide bonds containing both variable and constant domains. The variable 
domain, responsible for antigen binding is generated by recombination of a set of 
germline variable (V), diversity (D) and joining (J) gene segments. This process, called 
VDJ recombination, is accompanied by the addition and deletion of nucleotides at the 
junctions between ligated gene segments. Because of the combinatorial and non-
templated nature of the mechanisms that generate these junctions, the heavy-chain 
complementarity-determining regions 3 (HCDR3) is the most diverse component and is a 
principal determinant of Ab specificity.16 In addition to the combinatorial and junctional 
diversity, Ig haplotype and allelic diversity play a key role in contributing towards 
diversity of the primary Ig repertoire17,18. B cells undergo further diversification when 
they encounter antigens in the germinal center of secondary lymphoid organs. B-cells 
undergo proliferation stimulated by co-stimulatory signals and T-cells in germinal centers 
by the process of clonal expansion which followed by somatic hypermutation where 
activation-induced cytidine deaminase induces mutations in the Abs. B cells bearing the 
mutations that increase the affinity of the Abs undergo preferential expansion and 
survival, a process referred to as affinity maturation. These B cells expressing somatically 
mutated, high-antigen-affinity BCRs differentiate into memory B cells or plasma cells18. 
These memory B cells generated by vaccines are rapidly reactivated upon exposure to a 
pathogen.   
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Genomic approaches towards generation of an HIV vaccine:  
BnAbs are particularly difficult to elicit because they undergo complicated affinity 
maturation pathways and possess long, hydrophobic HCDR3s with several insertions and 
deletions in the Ab variable regions19,20. Additionally, these bnAbs require use specific Ig 
V genes and allelic variants that contribute to their breadth and potency21–23. With the 
advent of next generation sequencing and rational immunogen design strategies, several 
potent bnAbs20,24–26 have been isolated and important insights have been gained 
sequencing the Immunoglobulin (Ig-seq) repertoire of infected individuals22,26,27. 
Studying the Ig repertoire in HIV-1 infected individuals, has provided useful information 
on the path of affinity maturation leading to bnAbs. Time-ordered sequencing of evolving 
virus populations and antibody responses in the same host, together with isolation of 
bnAbs, has helped in understanding the dynamic between the adaptive immune responses 
which exert selective pressure on the virus and the emergence of viral escape mutants27. 
Thus, tracing the evolutionary paths that lead to the generation of bnAbs is critical for the 
design of effective immunogens and vaccination schedules that will elicit an immune 
response steered toward an affinity maturation pathway leading to the production of 
bnAbs21.  
 
Identification of clonally related antibodies to infer antibody lineages leading to the 
evolution of protective antibodies, starting from an unmutated common ancestor requires 
germline sequence information. Additionally, understanding the degree of genetic 
variation in macaques is critical for assessing VDJ segment usage, estimating somatic 
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hypermutation and comparing antibody responses among individuals and translation to 
human studies. For example, an immunogen, eOD-GT6, was engineered to be used as an 
HIV-1 vaccine prime successfully bound human IGHV1-2*02, but did not bind to rhesus 
IGHV owing to lack of critical residues in the corresponding rhesus germline gene22. This 
would imply that the efficacy of eOD-GT6 cannot be assessed in rhesus macaques. Thus 
characterization of the germline composition of the Ig region in these primate models is a 
prerequisite for fully understanding the extent to which the humoral response of these 
surrogate species truly mirrors that of humans. 
 
 
The first whole genome sequence of the macaque was sequenced in 200729. However, 
several sequencing and assembly errors resulting in the misannotations of a large portion 
of the genome have subsequently been reported30. Since then, two additional macaque 
whole genome sequences have also been published. Despite these sequencing projects, 
the immunoglobulin loci, central to understanding the macaque’s immunogenetics still 
remains poorly characterized. For example only 20 IGHV genes were annotated in the 
original genome. Sundling et al., subsequently improved Ig annotations in the original 
genome31, however considering that the original genome has several sequencing and 
assembly errors, we believe that the Ig locus requires further characterization. 
Additionally, other studies aimed at obtaining the macaque Ig locus used human 
primers32–35 thus biasing the Ig information obtained. An unbiased, high quality, whole 
genome sequence of the macaque with especially high quality sequence of the 
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Immunoglobulin locus is necessary. In this dissertation we provide such a high quality 
whole genome sequence for the rhesus macaque using next generation sequencing 
techniques. Our sequence provides high quality information about the Immunoglobulin 
locus thus providing a better understanding of the immunogenetics of the macaque and 
helping the progress of using macaques as animal models for HIV vaccine development. 
To further understand allelic diversity of the Ig locus, we also baited-and-sequenced Ig 
from nine additional macaques. Our project will provide us with Ig allelic information 
that was not previously available and will allow for the development of new tools for 
primate biology. 
 
 
 
 
 
 
  
 
 
 
 8 
 
CHAPTER TWO: RHESUS MACAQUE IMMUNOGENETICS THROUGH DE 
NOVO GENOME ASSEMBLIES 
 
INTRODUCTION  
Over the last decade, researchers have isolated potent broadly neutralizing HIV-1 
antibodies (bnAbs)13,15,19,20,22,25,27,36,37 in humans, that require particular Variable (V), 
Diversity (D) and Joining (J) genes in the germline Ig locus to efficiently neutralize a 
broad spectrum of the HIV-1 virus variants. Understanding the pathways that lead to the 
development of bnAbs is key to the development of a rational HIV vaccine. Considering 
that rhesus macaques are currently the best animal models available for HIV vaccine 
research, it is imperative to understand the genetics of the macaque Ig locus. This will 
enable better understanding of Ig repertoire studies in pre-clinical trials and optimal 
translation of macaques as animal models. In this chapter, I will discuss the genetics of 
the macaque Ig locus and its application to HIV vaccine development. 
 
Though the first whole genome sequence for the rhesus macaque was published in 
200729, our understanding of macaque germline variability at the Ig locus remains 
severely limited. Macaque genomic sequence data are incomplete and the Ig locus itself 
is complex and highly repetitive. In addition, the existing whole genome sequence 
(WGS) of the macaque is poor quality, with over 50% of the genome misannotated due to 
several contig misassemblies and sequencing errors30. To address this issue, we have 
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assembled a high quality Ig locus [Ig heavy chain: IGH, Ig light chain: IGL and IGK] 
from one Indian rhesus macaque and sequenced at high coverage the Ig locus from nine 
additional Indian rhesus macaques to study allelic diversity.    
 
METHODS   
Generation of a high-resolution Ig locus: We used a combination of short reads and 
long reads generated using next generation sequencing strategies from a rhesus macaque 
of Indian origin to obtain a high-quality Ig locus. In addition, we performed baited Ig-
sequencing from nine additional macaques of Indian origin and integrated this allelic 
diversity information with the high-quality Ig locus to obtain a high-resolution Ig locus. 
 
Whole genome sequence library preparation: In order to obtain the complete Ig locus, 
we sequenced the whole genome of the macaque using two complementary, Illumina 
sequencing strategies. Genomic DNA was extracted from macaque ovum of an Indian-
origin rhesus macaque using the Qiagen Blood and Tissue kit to obtain a concentration of 
101ng/ul of DNA. Eight libraries of three insert sizes (Standard: 400bp, Mate pairs: 
3000-5000bp, 8000-11000bp) were constructed and sequenced in a paired end manner on 
an Illumina HiSeq2500 at 110X coverage. We will refer to reads obtained from this 
strategy as PMPs (Paired end and Mate Pair reads). Secondly, we used the Illumina 
TruSeq technology to obtain long reads (1,500-20,000bp) for the whole genome sequence 
of the Rhesus Macaque. Genomic DNA was extracted from the same Indian-origin 
macaque and the libraries were prepared and sequenced using the Illumina TruSeq 
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technology. We will refer to reads obtained from this strategy as SLRs (Synthetic Long 
Reads). 
 
Assembly of high quality Ig locus: We used multiple genome assembly strategies to 
assemble the high-quality Ig locus and in the following section, we discuss the genome 
assembly strategy that worked best for each Ig locus. 
 
IGH assembly: To ensure that the reads obtained from the Illumina runs (PMPs and 
SLRs) were of good quality, we performed quality control of the reads using the 
FASTQC38 toolkit. All  low quality reads (PHRED<20) and adapter sequences were 
clipped using Trimmomatic39 and the high quality, trimmed reads were used as inputs for 
genome assembly. We used SOAPdenovo240, a de-brujin graph assembler, to assemble 
all the PMPs representing the whole genome of the rhesus macaque. We optimized the 
parameters for the assembly, and the optimal assembly (K-mer=69) was chosen using 
assembly statistics generated by QUASTv2.341.The gaps in the assembly were closed 
using GapCloser40 and contigs less than 1000bp were discarded. Next, we scaffolded the 
assembly using PMPS—SSPACE-standard42 and SLRs—SSPACE-LongRead43. Finally, 
we used transcriptome data29 and scaffolded the assembly using L_RNA_scaffolder44.  
We used African green monkey, Cynomolgos macaque and human IGH as queries in 
BLAST+ to obtain the contigs representing the rhesus macaque IGH locus.   
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IGL and IGK assembly: We used Celerav8.1 to assemble all the SLRs generated from 
Illumina TruSeq. Reads obtained using the TruSeq strategy have been shown to have low 
error rates. As the SLRs share some characteristics with consensus-corrected PacBio 
reads, we applied the Celera Assembler parameters recommended for PacBio data to take 
advantage of the read length and low error rate. We optimized the parameters for the 
assembly, and the optimal assembly was chosen using assembly statistics generated by 
QUASTv2.341. We used African green monkey, Cynomolgos macaque and human IGL 
and IGK as queries in BLAST+ to obtain the contigs representing the rhesus macaque 
IGL and IGK locus.    
Simultaneously, using African green monkey, Cynomolgos macaque and human IGL and 
IGK as queries in BLAST+, we identified all the IGL and IGK reads from PMPs dataset. 
These “baited-Ig” 150bp reads, along with the IGL and IGK contigs obtained from the 
SLR assembly were used as inputs for genome assembly using SPAdesv3.045. The short 
reads were assembled using multiple k-mers 55, 65, 75, 85, 95, 105 and 125 and the 
optimal assemblies were identified using assembly statistics generated by QUASTv2.3. 
The optimal assemblies were then combined using Metassembler46, to obtain a single 
superior assembly.  
 
Contig ordering and annotation of the high-quality Ig locus: To complete naming of 
the rhesus macaque Ig genes, we ordered the assembled contigs against the complete Ig 
locus of the African green monkey using MUMmer47. The order was assigned based on 
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highest percent identity, contig coverage and consistent alignment with respect to the 
query Ig locus—when one of these criteria were inconsistent, the contig order remained 
undecided. The genes on the Ig locus were identified and annotated based on homology 
to known Ig genes sequences in NHP and humans available through IMGT. The Variable 
(V) genes in the Ig locus were identified based on identification and evaluation of 
recombination signals, in-frame coding sequence with invariant Cysteines, leader regions 
and splice sites. A gene was classified as functional (F) if it contained all the essential 
features described above. If the putative V gene had no stop codons in the coding region, 
it was classified as an Open Reading Frame (ORF); if it lacked the essential features of a 
V gene and/or has stop codons, we will classified it as a non-functional (NF) gene. The 
Diversity (D) and Joining (J) genes were identified based on identification and evaluation 
of recombination signals and in-frame coding sequence with the presence of invariant 
Tryptophan for J genes. If the putative D/J gene had no stop codons in the coding region 
with intact recombination signals, it was classified as F; other D/J genes lacking these 
features were classified as NF. The Constant region (C) genes were identified and 
evaluation of on in-frame coding sequence and splice sites. If the putative C gene had 
intact in-frame sequence and splice junctions, it was classified as F. C genes lacking these 
features were classified as NF. 
 
Ig baiting and sequencing strategy: To obtain further information on the allelic 
diversity of the Ig locus in the rhesus macaque, we performed Ig baiting-and-sequencing 
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from nine additional macaques. Agilent bait sequences were created by aligning human 
Ig  and TCR germline sequences from IMGT48 against  the rhesus macaque genome, 
“rheMac2”, using BLAST+. The contiguous alignment coordinates were then used to 
extract the appropriate sequences from the genome.  These sequences, which represent 
the Ig and TCR locus on the macaque genome, were then submitted to Agilent to create a 
custom bait library.  The resulting baiting library covered approximately 2MB of the 
macaque genome with 2x tiled baiting. 
 
Genomic DNA was extracted from skin punches of nine Indian-origin rhesus macaques 
using the Agilent SureSelect gDNA Extraction Kit. 1-3 µg of the gDNA was then sheared 
using the Covaris E-Series Sample Preparation system into 150-200 base pair fragments. 
gDNA libraries were prepared according to the protocol provided in the SureSelect XT 
Target Enrichment System Kit for Illumina Multiplexed Sequencing manual. The 
prepared DNA libraries were then mixed with the SureSelect Capture Library, which 
consists of the biotinylated RNA library “baits” that are complimentary to the target 
region on the prepped library. Streptavidin-coated magnetic beads attach to the baits that 
have hybridized to the target region and are then magnetically separated from the 
unbound DNA fraction. The baits were then digested, leaving only single-stranded target 
DNA. A final PCR was performed to amplify the captured DNA content and to add 
indices to the target DNA. The samples were then pooled in preparation for 100 base-
pair, paired-end multiplexed sequencing on the Illumina HiSeq platform.  Following 
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sequencing, the sequencing reads were trimmed to remove adaptor sequence and low 
quality bases. 
 
De-novo assembly and annotation of the Ig locus: To ensure that the reads obtained 
from the HiSeq run were of good quality, we carried out quality control of the reads using 
the FASTQC38 toolkit. We used the cutadapt toolkit to eliminate poor quality reads 
(PHRED<20) and remove adapter sequences. Next, we assembled the reads de-novo 
using SPAdes2.445. We optimized the assembly at various k-mer values and selected the 
optimal assembly using assembly statistics generated by QUAST2.349. Annotation of the 
Ig locus was carried out in the same manner as described in the previous section.  
 
High-resolution Ig locus: To obtain the high-resolution Ig locus, we integrated allelic 
diversity information from the Ig allele library with the reference, high-quality Ig locus 
using BLAST+. The Ig genes, from the high-quality Ig assembly, were used as BLAST+ 
queries against all the genes in the Ig allele library. A gene from the genomic library was 
considered an allele of the reference Ig gene if nucleotide percentage similarity was 
greater than 90%. When nucleotide percentage similarity was less than 90%, it was 
considered a different gene that was missing/unidentified in the reference assembly. 
 
Studying diversity of rhesus macaques with respect to humans: Multiple sequence 
alignments were generated using ClustalW or MUSCLE in Bioedit and MEGA6.050 
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respectively. Dotplots were generated using YASS51. We studied both intraspecies and 
interspecies diversity of the macaques with respect to humans using maximum likelihood 
phylogenetics. Maximum likelihood trees were generated using MEGA6.050. The 
branches on the trees were colored using Rainbow Tree. Human Ig genes and alleles that 
were used in the analysis were downloaded from IMGT. Gene conversion signatures in 
macaque Ig V genes were identified by manually scanning V gene alignments were 
generated using ClustalW. Positions containing N in the alignments were omitted for 
gene conversion/crossover analysis.  
 
RESULTS 
Generation of a high quality Ig locus:  
 
IGH assembly: We obtained 1,783,194,556 reads [400bp, standard inserts], 109,184,438 
reads [3-5kb inserts] and 101,348,328 reads [8-11kb inserts] using Illumina 150bp, paired 
end sequencing representing the whole genome. These reads were assembled using 
SOAPdenovo240 (K-mer=69) 40and the gaps in the assembly were closed using 
GapCloser40. Contigs less than 1000bp were discarded and the remaining contigs were 
further scaffolded using SSPACE-standard42.Using the TruSeq strategy, we obtained 
9,784,340 SLRs varying in length between 1,500-20,000bp and these were used to further 
scaffold the contigs using SSPACE-LongRead43. Finally, we used transcriptome data29 
and scaffolded the assembly using L_RNA_scaffolder44.  29 scaffolds representing the 
IGH locus were identified using African green monkey, Cynomolgos macaque and 
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human IGH as queries in BLAST+ to obtain the contigs representing the rhesus macaque 
IGH locus.   
 
IGL and IGK assembly: We assembled the SLRs de novo using Celerav8.1 into 
130,130 contigs with 26,559 contigs representing 50% of the whole genome sequence. 
Using the African green monkey, Cynomolgos macaque and human IGL and IGK as 
queries in BLAST+, we obtained 2705 contigs representing the rhesus macaque IGL and 
IGK locus. Simultaneously, African green monkey, Cynomolgos macaque and human 
IGL and IGK were also used as queries in bowtie252 against the PMP dataset, to obtain 
50,703,106  ‘baited-Ig’ reads. The baited-Ig reads and contigs, were used as inputs for 
genome assembly using SPAdesv3.045, and the optimal assemblies were further 
combined using Metassembler46, to obtain 3 and 8 contigs representing the rhesus 
macaque IGL and IGK locus respectively. 
 
IG contig ordering: The 29 assembled macaque IGH contigs were ordered against the 
complete IGH locus of the African green monkey using MUMmer47.  Based on the 
alignments of the query to the reference IGH locus, 9 scaffolds were ordered to represent 
the rhesus macaque IGH locus and 16 scaffolds were additionally ordered to represent a 
‘sister’ macaque IGH locus. 4 scaffolds could not be placed. One of the ‘sister’ IGH 
contigs, scaffold 5775, had 2 conflicting coordinates on the African green monkey IGH 
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locus: positions 1,401,047 to 1,454,449bp or 1,472,966 to 1,575,244bp. In both these 
cases, final contig order was unaffected.  
 
The 8 assembled macaque IGK contigs were ordered against the African green monkey 
IGK locus to represent 4 IGK and 4 ‘sister’ scaffolds. Similarly, the 3 assembled 
macaque IGL contigs were ordered against the African green monkey IGL locus.   
 
IGH  
Genes in the IGH locus were identified and annotated using essential Ig gene features 
described in the methods section. A total of 105 IGHV (44 functional, 61 Non-
functional), 39 IGHD, 9 IGHJ genes and 9 constant region genes were identified. Figure 
1A represents a schematic of the rhesus macaque IGH locus. Figures 1B and 1C represent 
a schematic of the macaque J and the D locus respectively.  
 
IGHV cluster: A total of 178 IGHV genes (71 functional) belonging to 7 IGHV families 
were found in the rhesus macaque. The contigs containing these genes were ordered 
based on similarity to the African green monkey IGH locus and 9 contigs were ordered to 
represent the rhesus macaque IGHV cluster. The largest of the IGHV contigs (1.4Mb), 
contained 55 IGHV genes and all the IGHD, IGHJ and IGHC genes. We identified 44 
functional IGHV genes belonging to 7 families (figure 2), 20 functional genes on the 
‘sister’ IGH locus and 7 functional genes on contigs that could not be placed. Table 1A 
represents the list of all the genes that were identified before ordering; functional genes 
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that were identified on the IGH, ‘sister’ IGH locus and contigs that could not be ordered. 
It is important to note that the IGHV genes identified on the ‘sister’ IGH contigs, showed 
several structural variations with respect to the main rhesus macaque IGH scaffold that 
was ordered. Figure 1D details these structural variants found between IGH and ‘sister 
IGH’ contigs.  
1A 
 
 19 
 
1B 
 
 
1C 
 
1D 
 
Figure 1: 1A: Schematic representation of the rhesus macaque IGH locus. The text on the 
left of the IGH schematic indicates the IGH scaffold number (S1-S9) that was determined 
by ordering the rhesus macaque IGH scaffolds against the African Green Monkey IGH 
locus. The map should be read from top to bottom, right to left. The nomenclature for V 
genes was ‘IGHV family-position with respect to the D cluster’.  Functional, ORF and 
non-functional IGHV genes are represented. 
1B: Schematic representation of the rhesus macaque IGHJ cluster. The nomenclature 
used for J genes was ‘J-IGHJ family-position with respect to the D cluster’.  An –P 
indicates a non-functional/pseudogene. 
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1C: Schematic representation of the rhesus macaque IGHD cluster. The nomenclature 
used for D genes was ‘D-IGHD family-position with respect to the V cluster’ 
1 D: structural variants observed between the main (red) and ‘sister’ (blue) IGH scaffolds 
in the rhesus macaque. 
 
  
Figure 2: Maximum likelihood phylogenetic tree of rhesus IGHV functional genes from 
the high quality macaque. The Ig V gene families are represented by different colors (see 
figure legend). 
 
IGHD, J and C cluster: All the IGHD, IGHJ and IGHC genes were assembled onto one 
scaffold. 39 functional IGHD genes belonging to 6 families were found—of these 5 pairs 
of IGHD genes and 1 triad of IGHD genes were identical. Table 1B lists all the functional 
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IGHD genes that were identified in the IGH. 9 IGHJ genes (6 functional and 3 
pseudogenes) were identified and IGHJ5 gene was duplicated in the rhesus macaque. 8 
IGHC genes were identified including one IGHA gene and 4 IGHG genes. An additional 
pseudogene (IGHEP) was assembled onto another scaffold.   
1A 
 
1B 
 
Tables 1A, 1B: 1A: List of all IGHV genes (functional, non-functional, ORF) 1B: IGHD 
identified in the high quality Ig macaque sequence  
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IGK  
Genes in the IGK locus were identified and annotated using essential Ig gene features as 
described in the methods section. After contig ordering, a total of 108 IGKV genes (54 
functional, 1 ORF, 54 Non-functional), 11 ‘sister’ IGKV functional genes, 5 IGKJ genes 
and 1 constant region gene was identified. Figure 3A represents a representation of the 
rhesus macaque IGK locus and Figure 3B represents the macaque IGKJ cluster.  
 
IGKV cluster: A total of 119 IGKV genes (table 2) belonging to 6 IGKV families were 
found in the rhesus macaque. 4 IGK and 4 ‘sister’ IGK contigs were ordered based on 
similarity to the African green monkey IGK locus. The largest IGKV contigs was 744kb 
and contained 63 IGKV genes.  We identified 54 functional IGKV genes belonging to 6 
families (figure 4), 1 ORF belonging to the IGKV2 family and 11 functional genes on the 
‘sister’ IGK locus. Table 2 lists the families of all the functional genes found on the IGK 
and ‘sister’ IGK scaffolds. Similar to the ‘sister’ IGHV scaffolds, the ‘sister’ IGKV 
scaffolds also exhibited structural variants (figure 3C) with respect to the main IGKV 
scaffolds. Functional IGKV genes were identified in both the forward and reverse 
complement orientation on the main IGKV scaffolds. 6 blocks of alternating IGKV genes 
were identified in the forward and reverse orientation with 2 large blocks of genes—26 
and 60 IGKV genes in the forward and reverse orientations respectively. 
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IGKJ, constant region genes: Along with 10 IGKV genes, the IGKJ cluster and the 
constant region gene was assembled onto one scaffold. The macaque IGKJ cluster 
contained 5 IGKJ genes [4 functional, 1 pseudogene (IGKJ5)]. One constant region gene 
(IGKC) was identified. 
3A 
 
3B 
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3C 
 
Figure 3: 3A: Schematic representation of the rhesus macaque IGK locus. The text on the 
left indicates the IGK scaffold number (S1-S4) determined by ordering the rhesus 
macaque scaffolds against the African Green Monkey IGK locus. The map should be 
read from bottom to top, left to right. The nomenclature used for V genes was ‘IGKV 
family-position with respect to the J cluster’.  Functional, ORF and non-functional IGKV 
genes are represented. 
3B: Schematic representation of the rhesus macaque IGKJ cluster. The nomenclature 
used for J genes was ‘J-IGKJ family-position with respect to the V cluster’.  An –P in the 
label indicates a non-functional/pseudogene. 
3C: structural variants observed between the main (red) and ‘sister’ (blue) IGK scaffolds 
in the rhesus macaque.  
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Figure 4: Maximum likelihood phylogenetic tree of rhesus IGKV functional genes from 
the high quality macaque. The Ig V gene families are represented by different colors (see 
figure legend).   
 
Table 2: List of all IGKV genes (functional, non-functional, ORF) identified in the high 
quality macaque Ig sequence 
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IGL 
Similar to the other two Ig loci, genes in the IGL locus were identified and a total of 104 
IGLV (46 functional, 1 ORF, 57 Non-functional), 7 IGLJ genes and 7 constant region 
genes were identified. Figure 5A represents a schematic of the rhesus macaque IGL locus 
and Figure 5B represents the macaque IGL-JC cluster.  
 
IGLV cluster: The 3 macaque IGL contigs were ordered using African green monkey 
IGL locus. No ‘sister’ IGL contigs were identified. 104 IGLV genes (table 3) belonging 
to 11 IGLV families were found in the rhesus macaque. The largest IGLV contigs was 
800kb and contained 53 IGKV genes, and 7 alternating IGLJ and IGLC genes.  We 
identified 46 functional IGLV genes belonging to 10 families (table 3, figure 6), 1 ORF 
belonging to the IGLV5 family. No functional genes were identified in the IGLV9 
family. 
 
IGL-JC cluster: Along with 53 IGLV genes, the IGL-JC cluster was assembled onto one 
scaffold. 7 alternating IGLV and IGLC genes were identified—5 of the JC genes were 
functional, the JC-4 and JC-5 genes were non-functional. The IGLC2 and IGLC3 genes 
were identical to each other. 
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Table 3:  List of all IGLV genes (functional, non-functional, ORF) identified in the high 
quality macaque Ig sequence 
5A 
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5B 
  
Figure 5: 5A: Schematic representation of the rhesus macaque IGL locus. The text on the 
left indicates the IGL scaffold number (S1-S3) determined by ordering the rhesus 
macaque scaffolds against the African Green Monkey IGL locus. The map should be read 
from top to bottom, right to left. The nomenclature used for V genes was ‘IGLV family-
position with respect to the J cluster’.  Functional, ORF and non-functional IGKV genes 
are represented. 
5B: Schematic representation of the rhesus macaque IGL-JC cluster. The nomenclature 
used for J and C genes was ‘(J-IGLJ/C-IGLC) family-position with respect to the V 
cluster’.  An –P in the label indicates a non-functional/pseudogene.  
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Figure 6: Maximum likelihood phylogenetic tree of rhesus IGLV functional genes from 
the high quality macaque. The Ig V gene families are represented by different colors (see 
figure legend). 
Generation of Ig allele library: The Ig bait-and-sequence strategy was carried out on all 
the nine macaques and we obtained a total of 14.84 (±1.19) million reads. All the reads 
that were obtained were of high quality, with a PHRED score of above 28 across all the 
positions. After removing adapter sequences, we assembled the reads de novo from the 
macaques into multiple contigs using SPAdesv2.4. We optimized the assembly process 
using different k-mers and selected the optimal assembly using assembly statistics 
generated by QUASTv2.3. Table 4 represents the assembly statistics for nine rhesus 
macaques. Annotations of the Ig genes were based on homology to existing Ig sequences 
from NHP and essential Ig gene features.  
 
Table 4: Assembly statistics for the nine rhesus macaques sequenced using baiting-Ig 
sequencing approach 
 
IGH allele library: 
IGHV genes: 269 Functional/ORF IGHV genes were found in the nine macaques, of 
these 177 represented unique IGHV functional/ORF genes (155 functional, 22 ORF 
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IGHVs) which were divided into 7 IGHV families (table 5A). The largest number of 
genes/alleles were found in the IGHV3 family. To generate the IGHV allele library, 
genes from the nine macaques were integrated with the high quality macaque IGH locus 
and distinguished from alleles based on the parameters described earlier in the methods 
section. Figure 7 represents a phylogenetic tree of all the functional IGHV genes found in 
the high quality assembly (including the genes that could not be placed), ‘sister’ IGHV 
genes and genes that were added to the IGHV allele library from the nine rhesus 
macaques. The final IGHV allele library consists of 52 functional genes (178 alleles) 
belonging to 7 families (table 5B) with the IGHV3 family being the largest (33 IGHV 
genes, 115 alleles). In addition, 17 alleles were found for 7 functional genes that were 
identified on contigs that could not be placed (table 5C).  11 ORFs (22 alleles, (table 5B) 
were identified in the nine macaques, which were all absent in the high quality macaque 
IGH locus. Percent identity of the genes within each family was highly variable with 
maximum variation in IGHV3 family. Percent identity for IGHV1 varied between 91.5-
99.6%, IGHV2 93.3-96%, IGHV3 63.5-97.6%., IGHV4 84.4-100%, IGHV5 94.9% and 
IGHV7 83.1-100%.  
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Figure 7: Maximum likelihood phylogenetic tree of the rhesus IGHV functional genes, 
based on the final Ig allele library 
5A 
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5B 
 
5C 
 
Tables 5A-C: 5A: List of all functional/ORF IGHV genes identified in the 9 rhesus 
macaques 5B: List of all functional and ORF IGHV genes and alleles in the IGHV allele 
library. The number of genes in the table is represented as number of genes found in the 
high quality Ig sequence + number of genes added from Ig-baiting sequencing; 5C: List 
of all functional IGHV genes (location on IGH unknown) in the IGHV allele library  
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IGHD genes: 146 Functional IGHD genes were found in the nine macaques, of these 35 
represented unique functional IGHD genes, indicating that the IGHD genes are highly 
conserved. To generate a complete IGHD allele library, genes obtained from these nine 
macaques were integrated with the high quality macaque IGH locus to obtain a total of 49 
IGHD alleles.  
 
IGHJ genes: 56 IGHJ genes were found in the nine macaques representing 9 IGHJ genes 
and 11 alleles. 2 alleles were identified for the IGHJ1 and IGHJ3P genes. For one of the 9 
macaques (macaque 1), the entire IGHJ cluster was assembled onto one contig. This 
macaque had only 8 of the 9 IGHJ genes (4 functional and 4 non-functional IGHJ genes) 
with one IGHJ5P pseudogene. Of the nine macaques, all macaques contained only one of 
the two IGHJ5 genes.  With the exception of macaque 1, IGHJ5 was functional in the 
other 8 macaques.  The genes obtained from these nine macaques were compared to the J 
genes identified in the high quality IGHJ cluster—all 9 IGHJ genes were identical 
indicating that the IGHJ genes are highly conserved between macaques. Next, we 
compared the entire IGHJ locus obtained from the high quality IGH assembly to the 
IGHJ cluster assembled in macaque 1 (figure 8) and the dotplot indicates that the two 
sequences are highly similar. A Clustal alignment of these 2 clusters indicated that these 
sequences were 88% identical. We identified a 402bp in-del event in the high quality 
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IGHJ cluster with respect to the IGHJ assembly in macaque 1. Deletion of this 402bp in-
del, resulted in a 99.4% identity between the 2 IGHJ clusters.  
 
Figure 8: Dot plot between IGHJ cluster of high quality Ig sequence macaque (M0) and 
Macaque 1 (M1, obtained from Ig-baiting).  
 
IGHC genes: Owing to low coverage, constant region genes were assembled onto 
multiple contigs, hence the alleles represented in the following section represents alleles 
of individual exons and not the entire IGHC gene [coverage of IGHC genes: IGHA: 1-
3X; IGHD: 1-6X; IGHE: 1-3X; IGHEP: 1-3X; IGHM: 1-5X and IGHG: 2-18X]. Despite 
low coverage, the constant region genes found in the 9 macaques were either identical or 
closely related to C genes found in the other 8 independent, macaque assemblies. Table 
6A lists the number of sequences identified for every individual IGHC exon in the nine 
macaques and the corresponding number of unique alleles it represented. To generate the 
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final IGHC allele library, we compared the IGHC genes obtained from the high quality 
IGH assembly to the IGHC genes found in 9 macaques (table 6B). While the IGHD genes 
were identical in all ten macaques, the other IGHC genes (IGHA, IGHE, IGHM, IGHG) 
were highly diverse between macaques.  
 
 
Tables 6A, 6B:  6A: List of the total number of IGHC gene sequences and unique alleles 
(in parenthesis) found in the 9 rhesus macaques. 6B: List of IGHC alleles (functional, 
non-functional) in the IGHC allele library. The * indicates that 2 copies genes are found 
in the macaque genome. 
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IGK allele library: 
IGKV genes: 272 Functional/ORF IGKV genes were found in the nine macaques, of 
these 198 represented unique IGKV functional/ORF genes (169 functional, 29 ORF 
IGKVs). These 177 genes were divided into 7 families (table 7A) with the largest number 
of alleles in the IGKV1 and IGKV2 family. Functional genes were identified in the 
IGKV5 family and IGKV ORFs were identified in the IGKV1, IGKV2 and IGKV5 
family. To generate the IGKV allele library, genes obtained from these nine macaques 
were integrated with the high quality macaque IGK locus and genes were distinguished 
from alleles based on the parameters described earlier in the methods section. Figure 9 
represents a phylogenetic tree of all the functional IGKV genes found in the high quality 
assembly, ‘sister’ IGKV genes and genes added to the IGKV allele library from the nine 
rhesus macaques. The final IGKV allele library consists of a total of 61 functional genes 
(212 alleles) belonging to 7 families (table 7B). 2 genes (5 alleles) were identified in the 
IGKV5 family. In addition, 9 IGKV ORF’s (30 alleles) were identified (table 7B).  
Percent identity of the genes within each family was highly variable—identity of IGKV1 
varied between 78.3-96.5%, IGKV2 69.8-99%, IGKV3 89.1-95.4%., IGKV5 88.5%, 
IGKV6 85.3% and IGKV7 68.2%. The IGKV7 gene identified in the nine macaques was 
very different from the IGKV7 gene in the high quality macaque indicating that this 
could either represent a separate family or that genes in the IGKV7 family are highly 
variable. 
 37 
 
 
 
Figure 9: Maximum likelihood phylogenetic tree of the rhesus IGKV functional genes, 
based on the final Ig allele library 
 
 38 
 
 
Tables 7A, B: 7A: List of all functional/ORF IGKV genes identified in the 9 rhesus 
macaques. 7B: List of all functional and ORF IGKV genes and alleles in the IGKV allele 
library. The number of genes in the table is represented as number of genes found in the 
high quality Ig sequence + number of genes added from Ig-baiting sequencing.  
 
IGKJ genes: The IGKJ cluster was assembled into one contig each for each of the nine 
macaques. The macaque IGKJ cluster contained 5 IGKJ genes [4 functional, 1 
pseudogene (IGKJ5)]; which were identical in all 9 macaques. The entire IGKJ cluster 
was highly conserved in all 9 macaques—percent identity varied between 99.1-99.9%. 
When integrated with the IGKJ genes in the high quality macaque to generate the IGKJ 
allele library, we observed that the genes in the high quality macaque were identical to 
the IGKJ genes in the 9 macaques indicating that the IGKJ cluster is highly conserved. 
Additionally, the IGKJ cluster in the high quality macaque was identical to the IGKJ 
cluster in one of the nine macaques. 
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IGKC genes: The constant region gene, IGKC, was identified in all 9 macaques. Of 
these 9 IGKC gene sequences, 6 represented unique IGKC alleles. When integrated with 
the IGKC gene in the high quality macaque to generate the IGKC library, we observed 
that the IGKC in the high quality macaque was identical to one of the IGKC alleles 
identified in the 9 macaques.  
 
IGL allele library: 
IGLV genes: 239 Functional/ORF IGLV genes were found in the nine macaques, of 
these 148 represented unique IGLV functional/ORF genes (127 functional, 21 ORF 
IGLVs) which were divided into 11 families. Functional genes were identified in all 11 
IGLV families, (table 8A) with the largest number of alleles in the IGLV1, IGLV3 and 
IGLV5 family. IGKV ORFs were identified in the IGKV1, IGLV3, IGLV4, IGLV5 and 
IGLV7 families (table 8A). Genes obtained from these nine macaques were integrated 
with the high quality macaque IGL locus to generate the complete IGLV allele library. 
Table 8B lists the final IGLV allele library—54 functional IGLV genes (155 alleles) and 
8 IGLV ORFs (21 alleles).  Figure 10 represents a phylogenetic tree of all the functional 
IGLV genes found in the high quality assembly and genes added to the allele library from 
the nine rhesus macaques. Percent identity of the genes within each IGLV family was 
highly variable—identity of IGLV1 varied between 82.4-96.6%, IGLV2 83.1-100%, 
IGLV3 60.3-100%., IGLV4 68.4%, IGLV5 66.8-94.5%, IGLV6 90.6-97.9% and IGLV7 
90.4-95.9%. 
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Figure 10: Maximum likelihood phylogenetic tree of the rhesus IGLV functional genes, 
based on the final Ig allele library 
8A 
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8B 
 
Tables 8A, B: 8A: List of all functional/ORF IGLV genes identified in the 9 rhesus 
macaques. 8B: List of all functional and ORF IGLV genes and alleles in the IGLV allele 
library. The number of genes in the table is represented as number of genes found in the 
high quality Ig sequence + number of genes added from Ig-baiting sequencing. 
 
IGLJ genes: 41 IGLJ genes were found in the nine macaques to represent 10 functional 
IGLJ genes/alleles. IGL4 and IGL5 had mutated recombination signal sequences and 
were non-functional. The 10 alleles identified in the nine macaques were integrated with 
the IGLJ genes identified in the high quality macaque and with the exception of IGLJ3, 
all other J genes were identical. The final IGLJ allele library consists of 7 IGLJ genes (11 
alleles).  
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IGLC genes: Very few IGLC genes were identified in the nine macaques —16 IGLC 
genes, representing 12 unique genes/alleles. This indicates that the IGLC genes were 
highly diverse between macaques. Of the 12 alleles identified, only 2 (IGLC2/IGLC3 and 
IGLC4P) of these were identical to the IGLC genes identified in the high quality 
macaque. The final IGLC allele library consisted of 7 IGLJ genes (17 alleles).   
 
Interspecies Ig diversity: Comparing human and rhesus macaque Ig gene 
IGH  
IGHV genes: Humans have 53 functional IGHV genes (273 alleles) representing 7 
families and 23 ORFs (57 alleles). Table 9 lists genes and alleles found in each of the 
families in humans and macaques respectively. Both humans and macaques have similar 
number of genes, with the macaque IGHV3 family larger in comparison to humans. The 
allelic diversity exhibited in these ten macaques is on the same scale and the allelic 
diversity of the human IGHV genes—identified in several thousand individuals, implying 
that the macaque IGHV locus is highly polymorphic in these macaques. A phylogenetic 
tree (figure 11) of macaque and human IGHV genes indicates that while genes in the 
IGHV1, IGHV2, IGHV3, IGHV6 and IGHV7 families are interdigitated, genes in the 
IGHV4 and IGHV5 family segregate by species. Although the IGHV4 genes cluster by 
family, macaques contain 2 IGHV4 genes that are very close to the human IGHV4 genes. 
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Table 9:  List of human (IMGT) and macaque IGHV genes and alleles  
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Figure 11: Maximum likelihood phylogenetic tree of the human and rhesus IGHV 
functional genes. 
 
IGHD genes: Humans have 44 IGHD functional/ORF alleles that belong to 7 families. 
Of these 44 alleles, 23 represent functional IGHD genes and 14 represent ORFs. We 
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identified 49 alleles in macaques representing 39 IGHD genes that belong to six families 
implying that macaques have a larger number of IGHD genes in comparison to humans. 
Similar to their human counterparts, the IGHD genes in macaques are highly conserved. 
A phylogenetic tree (figure 12A) of macaque and human IGHD genes indicates that 
almost all macaque IGHD genes have corresponding human orthologs.  
 
IGHJ genes: Humans have 17 alleles representing 9 IGHJ genes (6 functional and 3 non-
functional genes). Macaques also contain 9 IGHJ genes; however unlike humans, 
macaques do not have a functional IGHJ2 gene, instead contain two copies of the IGHJ5 
genes.  A phylogenetic tree (figure 12B) of macaque and human IGHJ genes indicates 
that all macaque IGHJ genes have human orthologs. Pairwise identity between macaque 
and human functional IGHJ genes are over 90% for IGHJ1 (92.3%), IGHJ3 (90%) and 
IGHJ4 (93.7%), and much lower for IGHJ5 (78.4, 84.3%) and IGHJ6 (68.2%). 
 
IGHC genes: Humans have 57 IGHC alleles represented by 12 IGHC genes [2 IGHAs, 
IgD, IGHE, 2 IGHEPs, 4 IGHGs, IGHGP, IGHM]. In comparison, macaques have 8 
IGHC genes and differ from humans in that they lack an IGHG pseudogene, contain only 
1 IGHE pseudogene and IGHA gene. Table 10A indicates that macaque IGHC genes are 
a lot more diverse (except macaque IGHG) in comparison to human IGHC genes. 
Pairwise identity between macaque and human exons indicates that all IGHC exons are 
over 80% similar to their human counterparts (table 10B). A phylogenetic analysis 
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(figure 12C) of macaque and human IGHG exons indicates that all macaque IGHG genes 
segregates by species.  
12A 
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12B 
 
12C 
 
 
Figures 12A-C: Maximum likelihood phylogenetic tree of the human and rhesus (A) 
IGHD (B) IGHJ (C) IGHG genes.  
 48 
 
10A 
 
10B 
 
Tables 10A, 10B: 10A: List of human (IMGT) and macaque IGHC alleles. 10B: pairwise 
identity of human and macaque IGHC exons. 
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IGK 
IGKV genes: Humans have 41 functional IGKV genes (67 alleles) representing 6 
families and 10 ORFs (16 alleles). Table 11 lists genes and alleles found in each of the 
families in humans and macaques respectively. Both humans and macaques have similar 
number of genes, with the macaque IGKV2 family larger in comparison to humans. The 
macaque IGKV genes are much more polymorphic in comparison to the human IGLV 
genes. In addition, unlike macaques, humans lack functional genes in the IGKV7 family. 
A phylogenetic tree (figure 13) of macaque and human IGKV genes indicates that genes 
all genes in the 6 IGKV families are interdigitated. Similar to macaques, humans have 
functional IGKV genes in the forward and the reverse orientation. Humans have 3 
alternating blocks of IGKV genes—with 2 large blocks of IGKV genes—representing a 
duplication event in the human IGKV locus. While macaques have 6 alternating blocks of 
IGKV genes in the forward and reverse orientation, the 2 large blocks of genes in the 
forward and reverse orientation do not represent duplication events.   
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Figure 13: Maximum likelihood phylogenetic tree of the human and rhesus IGKV 
functional genes.  
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Table 11:  List of human (IMGT) and macaque IGKV genes and alleles  
 
IGKJ genes: Humans have 5 functional IGKJ genes (9 alleles). A phylogenetic tree 
(figure 14) of human and macaque IGKJ genes indicated that all macaque IGHJ genes 
have human orthologs. Macaques and human IGKJ genes shared high percent identity: 
IGKJ1, IGKJ4 and IGKJ5 were identical; IGKJ2 and IGKJ3 were 92.3% and 94.7% 
identical. 
 
Figure 14: Maximum likelihood phylogenetic tree of human and macaque IGKJ genes. 
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IGKC genes: Similar to macaques, humans have 1 IGKC gene (5 alleles). 6 alleles of the 
IGKC gene were found in 10 macaques, indicating that the IGKC gene is highly diverse 
in macaques, in comparison to humans. The pairwise identity between human and 
macaque IGKC is 91.6%. 
 
IGL 
IGLV genes: Humans have 33 functional IGLV genes (71 alleles) representing 10 
families and 7 ORFs (11 alleles). Table 12 lists genes and alleles found in each of the 
families in humans and macaques respectively. Unlike macaques, humans do not have 
any functional genes in the IGLV11 family. In addition, most IGLV families—IGLV1 to 
IGLV7 were expanded in macaques, in comparison to humans. Also, the macaque IGLV 
genes were a lot more polymorphic than their corresponding human counterparts. A 
phylogenetic tree (figure 15) of macaque and human IGLV genes indicates that genes in 
all the 10 IGLV families were interdigitated. 
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Figure 15: Maximum likelihood phylogenetic tree of the human and rhesus IGLV 
functional genes.  
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Table 12:  List of human (IMGT) and macaque IGLV genes and alleles  
 
IGLJ genes: Similar to macaques, humans have 5 functional and 2 non-functional IGLJ 
genes (10 alleles). Human IGLJ2 and IGLJ3 are identical. All macaque IGLJ genes, 
except for IGLJ2 and IGLJ3 have distinct orthologs (figure 16A). All macaques and 
human IGLJ genes shared percent identity above 80%–IGLJ1 (81.5%), IGLJ2 (84.2%), 
IGLJ3 (89.4%), IGLJ4P (84.2%), IGLJ5P (86.6%), IGLJ6 (89.4%) and IGLJ7 (81.5%).   
 
IGLC genes: Similar to macaques, humans have 5 functional and 2 non-functional IGLC 
genes (21 alleles). In the IMGT database, there are reports of the human IGLC6 gene 
being reported as non-functional—indicating that some humans have 4 functional and 3 
non-functional IGLC genes. In comparison, only 2 IGLC genes (IGLC4P and IGLC5P) 
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were non-functional in all ten macaques. When macaque IGLC genes were compared to 
humans to generate IGLC allele library, all the functional IGLC genes (IGLC1-3, IGLC6-
7) segregated by species. The non-functional genes, IGLC4P and IGLC5P had direct 
orthologs when compared to humans (figure 16B). All macaques and human IGLJ genes 
shared high percent identity--IGLC1 (93.7%), IGLC2 (93%), IGLC3 (92.1%), IGLC4P 
(88.4%), IGLC5P (86.7%), IGLC6 (94.6%) and IGLC7 (91.8%).    
Table 13 lists some of the important human neutralizing and bnAbs13 and their 
corresponding closest macaque V gene (heavy and light chain) orthologs in the rhesus 
macaque. In all of these bnAbs, human IGHV genes had corresponding IGHV genes in 
macaques with a sequence identity of over 85%. With the exception of human IGLV3-1, 
all human Ig light chain genes (IGKV and IGLV) had corresponding Ig V genes in 
macaques with a sequence identity of over 90%. 
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Figures 16A, B: Maximum likelihood phylogenetic tree of human and macaque 
functional (A) IGLJ (B) IGLC genes.  
 
Table 13: Heavy and light chain V gene usage in human neutralizing and broadly 
neutralizing bodies with corresponding macaque V genes orthologs 
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Role of gene conversion in species-specific segregation of Ig genes  
Phylogenetic analysis revealed that few Ig genes [IGH: IGHV4, IGHV5, IGHG; IGL: 
IGLJ2, IGLJ3, IGLC1-3, IGLC6, IGLC7] segregated by species in macaques and 
humans. Considering that gene conversion events have been reported in parts of the 
human genome that are highly polymorphic53, we wanted to test the hypothesis that these 
events occurred during speciation causing segregation of Ig genes by species. We 
carefully examined the relationship between the macaque and human Ig genes to identify 
signatures of gene conversion. In the case of the IGHV4 family, the closest human 
ortholog to macaque IGHV4-39 is human IGHV4-38 (figure 11). A pairwise alignment 
between human IGHV4-38 and macaque IGHV4-39 indicated that the first 102bp are 
identical (with exception of an in-del event at positions 91-93bp).  Additionally, a 
phylogenetic tree of the human IGHV4 genes indicates that IGHV4-38 is most closely 
related to IGHV4-39, IGHV4-59 is closest to IGHV4-61 and IGHV4-30 is closest to 
IGHV4-31. In addition, IGHV4-28, shares a close common ancestor with IGHV4-30 and 
IGHV4-31 (figure 11). Similar to IGHV4, the other human and macaque Ig genes that 
segregate by species are also located proximally to each other on the human Ig locus—
the IGHG region genes, IGLJ2 and IGLJ3; IGLC1-3, IGLC6 and IGLC7. The two non-
functional IGLC genes (IGLC4P and IGLC5P) did not segregate by species (figure 16B). 
Next, we studied the relationship between human Ig genes in two large Ig gene families 
that did not segregate by species—IGHV3 and IGLV3. In the case of IGLV3, we did not 
observe similarity of IGLV genes based on proximity of genes on the IGL locus (figure 
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17A). In the case of IGHV3, we observed two sets of IGHV3 genes that were most 
closely related to each other based on proximity on the Ig locus: IGHV3-30, IGHV3-33, 
and IGHV3-72, IGHV3-73 (figure 17B).  When we looked into segregation of these 
human IGHV3 genes with respect to macaques, we noted that IGHV3-30 and IGHV3-33 
genes segregated by species (figure 11).  
17A 
 
 
17B 
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Figure 17: Maximum likelihood phylogenetic tree of human (6A) IGHV3 and (6B) 
IGLV3 genes  
 
Next, we manually inspected macaque Ig V gene sequence alignments to identify 
signatures of gene conversion. We identified three cases (table 14) of signatures of gene 
conversion in the macaque Ig V genes. For example, in the IGHV1 family, we identified 
4 IGHV genes in 3 different macaques (Macaques 2, 3 and 9) that showed evidence of 
crossover. Both IGHV1-1-x4*01 and IGHV1-U6*03, found in macaque 9, were identical 
except for positions 1, 5 and 6. Similarly, IGHV1-38*03 and IGHV1-38*04, found in 
Macaques 3 and 2 respectively, were identical to each other with the exception of 
positions 1, 5 and 6. Finally, nucleotides 1-68 were identical between IGHV1-38*04 and 
IGHV1-1-x4*01 and nucleotide 69-288bp were identical between IGHV1-38*04 and 
IGHV1-38*03 indicating crossover events between these 2 gene sets. We identified 
similar, but shorter crossover events in the macaque IGHV2 and IGLV8 families (table 
14).  
 hIGLV3-16
 hIGLV3-25
 hIGLV3-10
 hIGLV3-27
 hIGLV3-22
 hIGLV3-1
 hIGLV3-19
 hIGLV3-9
 hIGLV3-12
 hIGLV3-21
0.05
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Table 14: Signatures of gene conversion in macaque Ig V genes. Monkey 0 indicates that 
the Ig V gene was identified in the high quality Ig assembly. Monkey 1-9 indicates that 
the Ig V genes were identified from the Ig-bait sequencing on the nine macaques.  
 
DISCUSSION 
We have assembled and characterized in detail the Ig locus (IGH, IGK and IGL) of the 
rhesus macaque. In addition to generating a high quality assembly, we have quantified 
allelic diversity at the Ig locus from nine additional macaques.  
 
Within-macaque diversity: We identified several structural variants in the rhesus IGHV 
and IGKV clusters indicating that within the same macaque, the V gene cluster of the Ig 
loci are highly heterogeneous. A larger number of structural variants were observed in the 
IGHV cluster in comparison to IGKV. These findings are similar to that reported at the 
human Ig locus—within the same human haploid genome, the human IGH was found to 
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be more genetically diverse than IGK and IGL54 respectively. We believe this large 
structural diversity is responsible for the lower quality assembly at the IGHV locus.   
 
Between-macaque diversity: We reported varying degrees of allelic diversity in the Ig 
genes between the ten macaques. While the V and C region genes were highly 
polymorphic, the D and the J genes were highly conserved between the ten macaques. 
 
Interspecies diversity between humans and macaques: In comparison to humans, we 
noted that several V gene families in all the three Ig loci were expanded in macaques. In 
addition, the diversity of the macaque Ig V genes was several times higher than observed 
in humans. For example, we identified 215 alleles for all functional IGHV genes in 10 
macaques, while only 273 functional IGHV alleles have been reported in the human 
IMGT database, a repository of all human Ig sequences that have been studied to date. 
We identified similar levels of allelic diversity in all three macaque Ig loci [222 alleles in 
human IGKV, 155 alleles in human IGLV, 215 alleles in human IGHV], which is 
strikingly different than reports in humans [67 alleles in human IGKV, 71 alleles in 
human IGLV, 273 alleles in human IGHV]. It is important to keep in mind that while the 
diversity of the Ig loci is a collection of all humans studied to date, no study has been 
undertaken to specifically understand the diversity of the human Ig loci is such detail. 
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We generated phylogenetic trees to study orthology of macaque Ig genes with respect to 
humans. While human orthologs were identified for most macaque Ig gene families, a 
few Ig gene families [IGH: IGHV4, IGHV5, IGHG; IGL: IGLJ2, IGLJ3, IGLC1-3, 
IGLC6, IGLC7] segregated by species. Interestingly, we noted that human Ig genes that 
segregated by species were located in close proximity on the Ig locus. For example, in the 
IGHV4 family, human IGHV4 genes that were most similar to each other were also in 
close proximity to one another [IGHV4-38 and IGHV4-39, IGHV4-59 and IGHV4-61, 
IGHV4-30 and IGHV4-31]. Furthermore, we observed high sequence homology at the 5’ 
end only between rhesus IGHV4-39 and human IGHV4-38. Based on these findings, we 
postulate that the human IGHV4-38 converted other human IGHV4 genes by multiple 
gene conversion events. Similarly in the IGL-JC cluster, all the functional C genes that 
segregated by species were proximally located. This relationship between Ig genes were 
not observed in families that did not segregate by species. Additionally, we identified 
signatures of gene conversion/crossover events in macaque Ig V genes (table 14). Taking 
these observations into account, we believe that similar to previous reports in other 
immune loci in primates and humans53,55, the Ig locus is rapidly diversifying and gene 
conversion events play a crucial role in contributing to its diversity and maintaining the 
functionality of this locus.  
 
We believe that the high levels of allelic diversity reported in the Ig V genes are accurate 
and not artefacts of sequencing error. Assembly and annotation of Ig loci obtained from 
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nine macaques identified Ig J and D genes that were identical to one another in all nine, 
independent assemblies. High degrees of polymorphisms were observed only in the 
macaque Ig V and C genes. Considering that human probes were used in the Ig-bait-and-
sequence strategy, we observed that in cases where human Ig genes were identical or 
shared a high percent identity to macaque Ig genes, we assembled high coverage 
macaque Ig counterparts. For example, in the case of IGKJ genes, three of the five 
macaque genes were identical to humans resulting in the complete assembly of IGKJ in 
all nine macaques. In contrast, when macaque and human genes segregated by species on 
a phylogenetic tree, we assembled lower coverage/no macaque (IGHC genes, IGLC 
genes, IGHV4, IGHV5 genes) Ig genes in the nine assemblies. Given the use of human 
probes, we believe that the true nature of Ig diversity is underrepresented in some of the 
Ig gene families that segregate by species.  
 
The germline Ig allele library that we have generated in this study will serve as a baseline 
to monitor Ig-responses in macaques immunized with putative HIV-1 vaccine candidates. 
A preliminary version of our allele library was used to study Ig responses in macaques 
immunized with the HIV-1 envelope and adjuvants12. Table 13 represents the closest 
macaque Ig V gene orthologs to some of the most important human bnAbs studied so far, 
and this information will aid in the rational design of HIV-1 preclinical trials. While most 
of these human Ig V genes, have corresponding macaque Ig V gene orthologs sharing a 
similarity over 90%, further experiments are required to validate similar function. Given 
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the high levels of intraspecies diversity observed in macaques, we believe that there is an 
urgent need to develop tools that can subsequently “correct” for macaque germline V 
genes to truly represent the germline V gene composition of the macaque of interest. This 
is essential to enable accurate predictions of clonal evolution of B-cells while performing 
B-cell lineage analysis in macaques immunized with putative vaccine candidates. 
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CHAPTER THREE: A NEW WHOLE GENOME SEQUENCE OF THE RHESUS 
MACAQUE AND COMPARISONS TO EXISTING RHESUS MACAQUE 
WHOLE GENOME 
 
INTRODUCTION 
In Chapter 1 of this dissertation, I outlined the importance of rhesus macaques as animal 
models in biomedicine.  Considering their wide applications in biomedicine, whole 
genome sequence in invaluable for the generation of genetic reagents. The first draft of 
the rhesus macaque genome was published in 200729, but several errors and 
misannotations have since been reported in the genome30. Recently, a new version of the 
genome has been published and is available in GenBank along with two more whole 
genome sequences from different monkeys. With new and improving sequencing and 
genome mapping technologies, we continue to improve the quality and our understanding 
of the important genomes56–58. While the new version of the Macaca mulatta NCBI 
RefSeq assembly, Mmul_8.0.1, is an improvement from its earlier version published in 
2007, additional macaque whole genome sequences are required to better characterize 
this animal model.  
Additional whole genome sequence information is also needed for analysis of the intra- 
and interspecies diversity of macaques with respect to humans. Knowledge of this 
diversity is important for correctly interpreting macaque models of human disease. For 
example,  Gibbs et al. noted that alleles reported as disease causing mutations in OTC 
deficiency, phenylketonuria and Sanfillipo syndrome in humans are normal alleles in 
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macaques29. A study on the variability between two subspecies of rhesus macaques and 
the crab eating macaque reported ~20 million SNPs and 740,827 in-del events between 
the three macaques59, which is much higher than the estimated average number of SNPs 
in humans (3.6 million)60. Another study reported similar findings of high diversity in 
rhesus macaques compared to humans61. Such knowledge of genetic variability in 
macaque models is crucial to ensure the optimal translation of research to the clinic. With 
this in mind, we employed new sequencing technologies with novel library preparation 
strategies (Illumina TruSeq technology, BioNano Irys optical mapping) to obtain a high 
quality genome of the macaque to generate additional tools to study primate genomics. 
 
METHODS 
Library preparation for the whole genome: Genomic DNA was extracted from 
macaque ovum of an Indian-origin rhesus macaque using the Qiagen Blood and Tissue 
kit to obtain a concentration of 101ng/ul of DNA. We used standard Illumina sequencing 
to obtain 150bp reads, at 110X coverage in a paired-end manner on an Illumina 
HiSeq2500. Six paired-end libraries were constructed, with insert sizes of 400bp and two 
mate-pair libraries with insert sizes of 3-5kb and 8-11kb. We will refer to reads obtained 
from this strategy as PMPs (Paired end and Mate Pair reads). Next, we used the Illumina 
TruSeq technology to obtain long reads (1,500-20,000bp) for the whole genome sequence 
of the Rhesus Macaque. This method uses a novel library preparation protocol where the 
macaque DNA is sheared into 10,000bp fragments, barcoded and sequenced on an 
Illumina HiSeq platform to generate short reads. The short reads are locally assembled 
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downstream using barcode information to obtain synthetic long reads of up to 20,000bp. 
We will refer to reads obtained from this strategy as SLRs (Synthetic Long Reads).  
 
Quality control and Genome assembly: To ensure that the reads obtained from the 
Illumina runs (PMPs and SLRs) were of good quality, we carried out quality control 
analysis using the FASTQC38 toolkit. All  low quality reads (PHRED<20) and adapter 
sequences were clipped using Trimmomatic39 and the high quality, trimmed reads were 
used as inputs for genome assembly. We used SOAPdenovo240, a de-brujin graph 
assembler, to assemble all the PMPs representing the whole genome of the rhesus 
macaque. We optimized the parameters for the assembly, and the optimal assembly (K-
mer=69) was chosen using assembly statistics generated by QUASTv2.341.The gaps in 
the assembly were closed using GapCloser40 and contigs less than 1000bp were 
discarded. Next, we scaffolded the assembly using PMPS—SSPACE-standard42 and 
SLRs—SSPACE-LongRead43. Finally, we used transcriptome data29 and scaffolded the 
assembly using L_RNA_scaffolder44.   
 
Irys mapping: To further improve the quality of the assembly and physically map the 
location of these scaffolds onto chromosomes, we performed Irys mapping. This method 
labels (BspQI label) uniquely identifiable sequence-specific pattern along the 
chromosome and captures high-resolution, single molecule images (BioNano consensus 
map) of the labelled DNA. The BioNano consensus maps were filtered with a minimum 
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length of 150kb and 8 minimum labels. A p-value threshold for the BioNano assembler 
was set to 1e-10 during the initial pair wise alignment stage and p-value thresholds for 
subsequent assembly stages were based off this value by AssembleIrysXeonPhi.pl. The 
BioNano IrysSolve de novo assembly pipeline utilized RefAligner and Assembler 
binaries version 4088 and pipeline scripts version 4125. An in silico consensus map was 
generated using the genome assembly obtained (from the previously described section)—
the fasta file was in silico nicked for BspQI label and in silico maps greater than 20 kb 
with more than 5 labels were retained for the assembly. A stringency of 1e-13 was used 
for alignment with in silico consensus maps as the anchor and BioNano consensus maps 
as the query.  Alignments were kept if alignment length was greater than 40% of the 
possible length and their confidence score was above 20. In order to include good 
alignments in lower label density regions of the genome, alignments were also kept if 
alignment length was greater than 90% of the possible length and their confidence score 
was above 15. These filtered alignments were used to generate super scaffold sequence 
contigs. We will refer to the genome assembly as Mmul5v1.0. 
 
Assessing quality of the genome: To assess the quality of the Mmul5v1.0, we mapped 
both DNA [50X sampled from PMPs] and RNA-sequences [SAMN03735004, 
SAMN00622009, SAMN02045724 and SAMN00706768] using bowtie252 and tophat62. 
In addition, we used CEGMA63 to provide a measure for quantitative assessment of 
genome assembly completeness.  
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Genome annotation: Repeats were identified and masked using RepeatMasker64. Next, 
we used BRAKER165, an unsupervised RNA-seq based pipeline for genome annotation 
that uses complementary strengths of GeneMark-ET and AUGUSTUS to make final gene 
predictions. RNA sequences from bioprojects SAMN03735004, SAMN00622009, 
SAMN02045724 and SAMN00706768 aligned to our masked genome were used as 
inputs for BRAKER1. The proteins that were predicted by BRAKER1 were verified 
against five other proteomes from NCBI RefSeq (Homo sapiens, Macaca mulatta, 
Macaca fascicularis, Pan troglodytes, Chlorocebus sabaeus) using BLAST-2.2.28+. A 
Bonferroni correction of 4.58E-07 was used to determine significant BLAST hits.  
 
Comparing Mmul5v1.0 to Mmul_8.0.1 (Macaca mulatta NCBI RefSeq): The proteins 
that were predicted by BRAKER1 were BLASTed against RefSeq Mmul_8.0.1 proteome 
to compare the two macaque genomes (Bonferroni correction=9.04E-07).  We used 
PANTHER66 to test whether proteins that were highly conserved (100% identical) had 
different biological functions in comparison to proteins that were poorly conserved (less 
than 70% identical). The PANTHER database uses Hidden Markov Models (HMMs) to 
annotate sequences from homologous sequences and classifies them based on their 
overall biological functions. The RefSeq protein accession IDs were converted to official 
gene symbols using bioDBnet and used as inputs for analysis in the PANTHER database. 
To study diversity between Mmul5v1.0 and Mmul_8.0.1, we aligned the Illumina paired-
 70 
 
end reads (PMPs) to Mmul_8.0.1 using bowtie2 and performed variant calling using 
samtools -0.1.19 and vcftools 0.1.14. We only retained variants supported by a mean read 
depth of over 20 and a PHRED quality score over 30. The functional significance of the 
variants was determined using the Variant Annotation Integrator (VAI) utility, provided 
by the UCSC genome browser. VAI uses gene annotations of the whole genome 
(Mmul_8.0.1) to make predictions and uses Sequence Ontology (SO) terms to describe 
the effect of each variant on genes. We grouped variants identified in UTR (5’ and 3’), 
introns, splice junctions and 5000bp upstream/downstream of a gene as variants possibly 
involved in gene regulation. We performed a statistical overrepresentation test using 
PANTHER to identify if variants associated with protein coding genes were 
overrepresented for GO-Slim biological processes.  
 
RESULTS 
Genome assembly: We obtained 1,783,194,556 reads [400bp, standard inserts], 
109,184,438 reads [3-5kb inserts] and 101,348,328 reads [8-11kb inserts] using Illumina 
150bp, paired end sequencing representing the whole genome. These reads were 
assembled using SOAPdenovo240 (K-mer=69) 40and the gaps in the assembly were closed 
using GapCloser40. Contigs less than 1000bp were discarded and the remaining contigs 
were further scaffolded using SSPACE-standard42.Using the TruSeq strategy, we 
obtained 9,784,340 SLRs between 1,500-20,000bp in length and these were used to 
further scaffold the contigs using SSPACE-LongRead43. Finally, we used transcriptome 
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data29 and scaffolded the assembly using L_RNA_scaffolder44 into 80,552 scaffolds 
representing 3.3Gb. The N50 of the assembly was 737Kb and L50 was 1116.  
 
Irys mapping: The BioNano consensus maps were assembled to generate 2371 contigs 
[N50=1.7Mb] representing a combined length of 2.9Gb. Alignment of the BioNano 
consensus maps to the in silico maps generated 496 supers scaffold contigs. These super 
scaffolds were then combined with the unaligned scaffolds to generate a total of 79,721 
scaffolds representing a combined length of 3.5Gb. The N50 of the Mmul5v1.0, after irys 
mapping was 1.3Mb and the L50 was 642. Figure 18 outlines the assembly pipeline (and 
details assembly statistics) used to assemble the whole genome.   
 
Figure 18: Whole genome sequence assembly pipeline with genome statistics 
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Assessing quality of the genome: 94.73% of the reads from the 150bp Illumina run 
(sampled at 50X) mapped to Mmul5v1.0. Table 15 outlines the percentage of RNA-seq 
reads from the four BioProjects [SAMN03735004, SAMN00622009, SAMN02045724 
and SAMN00706768] that mapped to Mmul5v1.0. When compared to Mmul_8.0.1, we 
observed that the percentage of RNA-seq reads that map to our version of the genome 
was slightly lower. In terms of quality of the assembly, we identified 207 (83.47%) and 
230 (92.74%) complete and partial CEGS respectively, indicating that a majority of the 
core set of genes were present in our assembly. In comparison, we identified 222 
(89.52%) and 232 (93.55%) complete and partial CEGS in Mmul_8.0.1. 
 
Table 15: Assessing Mmul5v1.0 quality using RNA-seq reads from four NCBI 
BioProjects. 
 
Genome annotation and other comparisons with Mmul_8.0.1: 1,457,973,941 bp 
(40.70 %) of 3,582,016,299 bp were masked used RepeatMasker. Table 16 lists the 
number and percentage of M. mulatta SINE, LINE, satellites, LTR, DNA elements that 
were masked before genome annotation. Next, RNA-seq reads aligned to the masked 
genome were used as input to BRAKER1.  BRAKER1 predicted 83,478 proteins, of 
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which 18,902 (Bonferroni=4.58E-07) functional proteins were identified using BLAST 
against the five NCBI RefSeq proteomes. Of these 18,902 proteins, 1573 proteins were 
100 % identical (complete query coverage) to one of the five NCBI RefSeq proteomes. 
When Mmul_8.0.1 was used as BLAST query, 15,653 proteins (Bonferroni=9.04E-07) 
were identified, of which 1345 proteins were 100% identical (complete query coverage). 
Analysis of biological processes using the PANTHER database between genes that were 
highly (100% identical) and poorly conserved (less than 70% identical) indicated that 
there was no difference between the two groups. 
 
Table 16: Numbers and percentage of M. mulatta repeat elements masked by 
RepeatMasker 
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Table 17 lists some of the proteins that were misannotated30 in the earlier version of the 
rhesus macaque assembly (ASM16755v2) and compares it to the annotations found in 
Mmul5v1.0. All the misannotations reported in the ASM16755v2 have been corrected 
subsequently in Mmul_8.0.1. Of the 10 misannotations reported30 in ASM16755v2, eight 
proteins were identified Mmul5v1.0, and all eight were annotated accurately.  In addition, 
we also identified novel isoforms of the proteins listed. 
 
Table 17: Comparisons of errors reported in the original macaque assembly 
(ASM16755v2), current version of Mmul5v1.0  and Mmul_8.0.1 
 
In comparison to Mmul_8.0.1, we identified 239 additional including proteins that play a 
vital role in the immune system—complement C4-B,  HLA class II histocompatibility 
antigens (DO, DR, DRB), killer cell immunoglobulin-like receptors (KIR2DL3, 
KIR3DL3, KIR2DS4) and regulatory processes—subunit 10 of cytochromeb-c1, cAMP-
dependent protein kinase regulatory subunit, heat shock protein HSP 90-alpha. The 
 75 
 
Mmul_8.0.1 proteome contains 13 functional Immunoglobulin heavy chain variable 
genes. We annotated 178 IGHV (71 functional), 108 (65 functional) IGKV and 104 (46 
functional) IGLV genes.  Though we did not perform a detailed annotation of the TCR 
locus, we identified 77 TRA, 95 TRB, 3 TRD and 11 TRG functional and non-functional 
V genes (unpublished) in Mmul5v1.0—the Mmul_8.0.1 proteome lacks functional TCR 
genes.  
We identified 8.81 million variants (7.62 million SNPs and 1.13 million indels) in 
Mmul5v1.0, when compared to Mmul_8.0.1 (table 18). 
 
Table 18: Variants identified in Mmul5v1.0 in comparison with Mmul_8.0.1 
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Of these, Variant Annotation Integrator annotated 8.67 million variants, and 90.3% (7.84 
million) of variants were annotated in intergenic variants and 9.4% (812,880) variants 
were annotated in the regulatory region. Additionally, 17,507 (0.02%) variants were 
identified in transcripts that were targets for Nonsense mediated decay (NMD). 6,085 
protein coding genes/transcripts were associated with the 836,394 variants. A statistical 
overrepresentation test indicated that variants in the protein coding genes were 
significantly overrepresented for immune processes (NF-kappaB, interferon-gamma, 
cytokine-mediated signaling pathway), metabolic and regulatory processes (Supplemental 
table 19).  
 
Table 19: Enrichment analysis of protein coding variants in Mmul5v1.0 with respect to 
Mmul_8.0.1 
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DISCUSSION  
Given that rhesus macaques are crucial animal models used in biomedical research, it is 
imperative to obtain high quality whole genome sequence information as a tool to 
understand intra and interspecies diversity of macaques with respect to humans. Using 
two complementary Illumina sequencing strategies (PMPs, SLRs) and Irys physical 
mapping, we have assembled a high-quality whole genome sequence and studied 
intraspecies diversity using the macaque RefSeq genome, Mmul_8.0.1.  While the overall 
assembly statistics of Mmul_8.0.1 are better than those of our genome assembly: 
Mmul5v1.0, Mmul5v1.0 is represented in fewer scaffolds and is highly contiguous.  
Comparisons of the two macaque whole genomes (Mmul5v1.0 and Mmul_8.0.1) 
indicated that the macaque intraspecies diversity is much higher (7.41 million SNPs and 
1.1million indels in autosomes) than observed in humans (3.6 million SNPs and 344Kb 
indel events in autosomes60). Additionally, 9.4% of the variation was found associated in 
regulatory regions; the role of which is yet to be understood in rhesus macaques. 
Enrichment analysis identified that variations were overrepresented in immune system 
genes; these findings are similar to reports from our previous study of high intraspecies 
diversity observed at the macaque immunoglobulin locus. Similarly, studies from other 
research groups61,67 and NHP immunogenetics databases68 (IPD-MHC and IPD-KIR) 
have also reported high inter- and intraspecies diversity at MHC class 1 and KIR genes.  
We identified additional proteins not annotated in Mmul_8.0.1, including missing 
components of the macaque HLA system and HLA class II histocompatibility antigens. 
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This is important as HLA typing is important in transplantation studies in macaques to 
avoid issues with analysis and interpretation of preclinical trial data. Additionally, 
knowledge of the genetics of the macaque HLA system is necessary to the study of 
autoimmune diseases and cancer studies69–71. Recently, high throughput sequencing of 
the immunoglobulin repertoire has led to tremendous insights into developing vaccine 
candidates against HIV-112,22,37,72—our annotations of the immunoglobulin locus 
provides the tools necessary to assess immunoglobulin-sequencing data, and comparing 
antibody responses in macaque preclinical trials which is necessary for designing 
successful vaccines1,73.    
 
Additional macaque genomes enable comparative genomic studies directly affecting the 
use of primate models in experimental protocols. For example, CYP17A1, plays an 
important role in drug metabolism and we identified 76 variants between the two 
macaque genomes. This knowledge of genomic differences is important for the 
interpretation of pharmaceutical studies74. Our sequencing project has led to the 
identification of several new isoforms of proteins previously unreported in GenBank. The 
results from this study demonstrates that new sequencing technologies along with robust 
and efficient assembly algorithms can lead to a better understanding of primate genomics. 
As additional primate genomes become available, this body of knowledge will grow, 
leading to the optimal use and interpretation of primate models of human disease.  
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CHAPTER FOUR: CONCLUDING REMARKS 
In this dissertation, we have assembled a high quality, immunologically detailed whole 
genome sequence of the rhesus macaque. In comparison to the published rhesus macaque 
genomes, we have improved the assembly and annotation of the whole genome at two 
important immune loci—the HLA system and the immunoglobulin locus. We have also 
obtained detailed information on allelic diversity of the immunoglobulin locus by 
employing the bait-and-sequencing technology from nine additional macaques. Our work 
provides the necessary genomic tools to aid with rational HIV vaccine design and optimal 
translation of rhesus macaques as animal models in other areas of biomedical research. 
 
Summary and implications of chapter 2: 
We sequenced and annotated a high quality Immunoglobulin locus (Heavy and Light 
chains) from one rhesus macaque and obtained information on allelic diversity by 
sequencing Ig from nine additional macaques. We identified several structural variants in 
the IGHV and IGKV clusters within the same macaque. One possible explanation of this 
variation can be attributed to genetic diversity of the parents of the macaque. A similar 
study of the human Ig locus revealed several large structural variants including insertion, 
deletion, segmental duplications, and complex rearrangements in the V region of all three 
Ig loci17,54. We also observed that the V genes are highly heterogeneous between the same 
species of macaques and the D and J genes were highly conserved. With the exception of 
IgD, all the Ig constant region genes were highly polymorphic between macaques. In 
comparison to humans, the IGKV and IGLV clusters were expanded in macaques. 
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Additionally, the diversity of the Ig V genes in these ten macaques was much larger that 
the diversity observed in all human Ig V genes alleles studied so far (IMGT database). We 
identified signatures of gene conversion at the macaque Ig V gene locus, and speculate that 
this mechanism might be responsible for extraordinary high diversity of the V genes 
observed within and between rhesus macaques. Sequence exchange between proximal and 
distal V clusters has previously been reported within the human IGK locus54.  
 
In this study, we have reported several important similarities and differences between the 
human and macaque Ig loci and believe that these results will impact HIV vaccine research. 
The Ig allele library provides insights into adaptive immune responses elicited by a 
pathogen challenge or vaccination. For example, particular human IGHV1-69 and IGHV1-
2 alleles are required for eliciting effective bnAbs against influenza and HIV-1, 
respectively22,75. Additionally, it will serve as a library for comparison against antibody 
sequence information to identify the essential mutations that make a potent antibody; the 
information generated can be used to rationally develop a broad array of tools. We believe 
that this data will enable the analysis of the antibody repertoire dynamics induced by 
experimental HIV-1 vaccine candidates ultimately leading to the development of an 
effective HIV-1 vaccine. For example, a preliminary version of our Ig allele library was 
used in a non-human primate study to B cell ontogeny and estimate somatic hypermutation 
parameters12. The aim of the study was to study affinity maturation and gain insights into 
bnAb development in macaques infected with SHIVAD8 and immunized with envelope 
protein and adjuvants. Using our allele library, the study concluded that the IGHV genes, 
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IGHV4A*01, IGHV4D*01 and IGHV3J*01 were specifically associated with neutralizing 
responses following SHIVAD8 infection and IGHV3Q*01 in protein/adjuvant 
immunization. This is particularly important as the IGHV3Q*01 human homologue gives 
rise to the CAP256-VRC26 family of bnAbs12 providing hope that these antibodies can 
potentially be elicited by vaccination. The information obtained in this dissertation, 
provides us with information to understand the polymorphisms in the Ig loci which will 
directly contribute to the optimal analyses of macaques in HIV pre-clinical trials.  
 
This is the first study undertaken in rhesus macaques to sequence, characterize and 
quantify allelic diversity of all three Ig loci. This study provides the necessary genomic 
tools required to use rhesus macaques for the study of adaptive immunity in human 
infectious disease. Further, high throughput sequencing of the antibody repertoire is 
invaluable for the isolation of antibodies relevant to disease, understanding immune 
repertoire development and immune dysregulation18. Thus, in addition to being beneficial 
to vaccine research, these data will help with the understanding of cancer disease 
progression, relapse and prognosis18.  
 
Summary and implications of chapter 3: 
We sequenced, assembled and annotated the whole genome of the macaque using recent 
next-generation techniques. In addition to improving the annotations of the 
immunoglobulin locus, we identified additional proteins in the HLA system, missing in 
previous macaque whole genome assemblies. Additionally we annotated several new 
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isoforms of protein coding genes. Genome wide comparisons against the existing 
macaque genome (Mmul_8.0.1) indicated that 90% SNPs were located in the intergenic 
regions and 9% of the SNPs were located in regulatory regions. 863,394 variants were 
associated with coding region genes, and an enrichment analysis of these variants 
indicated that immune system pathways were significantly enriched in comparison to 
other biological pathways. 
 
The whole genome sequence generated will serve as an additional tool for comparative 
non-human primate genomics. For example, the whole genome sequence obtained from 
this study, served as a baseline to study immunoglobulin allelic diversity in Chapter 2. 
Studies from other research groups61,67 and NHP immunogenetics databases68 (IPD-MHC 
and IPD-KIR) have indicated high inter- and intraspecies diversity at other immune loci 
such as MHC class 1 and KIR genes. This is important as progression to AIDS in humans 
is delayed in individuals carrying stimulatory KIR3DS1 receptor in combination with 
HLA-Bw4 with an isoleucine at amino acid position 80 76,77. Only one study has been 
reported showing longer survival and lower viral loads in rhesus macaques carrying 
KIR3DL05/KIR3DS05/KIR3DL10 along with Mamu-A1*001 allele78. Further 
characterization of allelic diversity at the whole genome level will enable better 
understanding of epistasis mechanisms at these complex loci. Another study indicated 
that macaque are three times more diverse than humans with one coding SNP in every 
gene61. In comparison to the existing macaque whole genome sequence, our study 
reported that a large proportion of variants were found in the regulatory regions of the 
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genome. Now that we have documented these differences, it is important to understand 
their functional consequence as they could potentially impact function and expression of 
both transcripts and protein coding genes. A detailed characterization of variations 
between humans and macaques will enable optimal use of these primate models in 
biomedical research.  
 
Obtaining additional macaque genomes will continue to improve our understanding of 
macaque biology and enable further comparative and genetic studies with humans and 
other non-human primates. The immediate impact our macaque genome, with improved 
annotations at certain immune loci will enable an improvement over current PCR-based 
methods to identify genes of interest in these regions, eliminating the need to use human-
specific primer sets to amplify macaque genes. We are also working with a team at Duke 
Human Vaccine Institute to better annotate another important immune locus—the TCR, 
with the ultimate goal of developing better primers for TCR repertoire analysis. Our 
knowledge regarding the sequence, structure and function of the human genome, 
continues to grow sixteen years after the first whole genome sequence was published. 
Only three rhesus macaque whole genome sequences have been published so far, and we 
will continue to gain knowledge of these animal models with improving sequencing 
technologies and additional high quality genome sequence information. 
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Limitations of this study: 
One of major limitations of this study is that the macaque Ig locus could not be assembled 
into a single scaffold. We believe that this is due to the highly repetitive and complex nature 
of the Ig locus. We tried to resolve this issue using long read, PacBio sequencing of the Ig 
locus. We failed at obtaining useful Ig sequence information twice—the sequencing reads 
obtained using this strategy were unable to improve the macaque Ig assembly. 
Additionally, reads obtained from the TruSeq technology did not provide adequate 
coverage of the Ig locus and a significant proportion of the reads obtained using this 
strategy was less than 10,000bp. Another limitation of this study was the use of Ig human 
probes for the Ig bait-and-sequence strategy. This was because the bait-and-sequence Ig 
libraries were made before we had access to a high quality Ig genome. The original 
assumption of the Ig bait-and-sequence strategy, was that human and macaque Ig gene 
sequences were orthologous and shared high percent identity. To assemble complete Ig 
loci onto one scaffold, future attempts should considering sequencing rhesus Ig BAC 
libraries using Sanger sequencing—this strategy has generated the highest quality human 
Ig locus available to date.  
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